Moderna Covid-19 vaccine is safe and appears effective in adolescents --company announcement

Primary tabs

Tue, 2021-05-25 13:43 — mike kraft

Moderna says its Covid-19 vaccine is safe and appears effective in adolescents Moderna's Covid-19 vaccine is safe and appears to be effective in adolescents, the company said Tuesday. John Bonifield and Lauren Mascarenhas, CNN CNN

(CNN) Moderna's Covid-19 vaccine is safe and appears to be effective in adolescents, the company said Tuesday.

In a Phase 2/3 trial of 3,732 children ages 12 to 17 in the United States, blood tests showed that the vaccine produced an immune response that was equivalent to earlier findings in adults.

The trial wasn't designed to look specifically at efficacy. However, initial observations found that none of the children who received the vaccine got sick with Covid-19 starting 14 days after their second dose. Four of the children who received the placebo tested positive for Covid-19, which Moderna says is "consistent with a vaccine efficacy of 100%." The company notes that figure could change as more data is collected.

In the trial, a case was defined as someone who had at least two coronavirus symptoms or one symptom and a positive Covid-19 test.

The company also reviewed how well the vaccine worked after just one dose. The results suggest the vaccine was 93% effective after one dose at preventing mild cases of Covid-19, involving only one symptom of coronavirus disease instead of two or more symptoms.

Moderna announced the results Tuesday in a news release, and the results have not yet been peer reviewed or published. ...

Moderna says it plans to submit the results to the US Food and Drug Administration in early June along with a request for authorization to use the vaccine in adolescents. It also plans to submit the data to a peer-reviewed publication.

The Moderna vaccine is already authorized for use in people ages 18 and older. ...

The FDA has already expanded the emergency use authorization for Pfizer/BioNTech's Covid-19 vaccine to include people ages 12 to 15 earlier this month. The vaccine had previously been authorized for people ages 16 and older. ...

Country / Region Tags:

General Topic Tags: